Portage Biotech Inc (PRTG)
NASDAQ:PRTG
US Market

Portage Biotech Inc (PRTG) Income Statement

13 Followers

Portage Biotech Inc Income Statement

Last quarter (Q2 2023), Portage Biotech Inc's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Portage Biotech Inc's net income was $-949.00K. See Portage Biotech Inc’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Mar 22Mar 21Mar 20Mar 19Mar 18
Total Revenue
-$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Cost of Revenue
------
Gross Profit
------
Operating Expense
$ 16.41M$ 15.59M$ 12.44M$ 5.98M$ 2.76M$ 2.23M
Operating Income
$ -16.41M$ -15.59M$ -12.44M$ -5.98M$ -2.76M$ -2.23M
Net Non Operating Interest Income Expense
$ 54.00K$ -43.00K$ -177.00K$ -546.00K$ 23.00K$ -24.00K
Other Income Expense
$ 401.00K$ 814.00K$ -2.27M$ 15.00K$ -853.00K$ 126.00M
Pretax Income
$ -15.95M$ -14.82M$ -14.89M$ -6.51M$ -3.59M$ 123.74M
Tax Provision
$ -171.00K$ 4.35M$ 2.30M$ 740.00K$ 0.00$ 0.00
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -13.51M$ -16.87M$ -15.83M$ -5.33M$ -2.63M$ 123.74M
Basic EPS
$ -1.00$ -1.29$ -1.35$ -0.49$ -0.55$ 46.21
Diluted EPS
$ -1.00$ -1.29$ -1.35$ -0.49$ -0.55$ 45.89
Basic Average Shares
$ 56.78M$ 13.06M$ 11.73M$ 10.95M$ 4.82M$ 2.68M
Diluted Average Shares
$ 56.78M$ 13.06M$ 11.73M$ 10.95M$ 4.82M$ 2.70M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 16.41M$ 15.59M$ 12.44M$ 5.98M$ 2.76M$ 2.23M
Interest Expense
$ 11.00K$ 43.00K$ 177.00K$ 557.00K$ 88.00K$ 24.00K
Net Income From Continuing And Discontinued Operation
$ -13.51M$ -16.87M$ -15.83M$ -5.33M$ -2.63M$ 123.74M
Normalized Income
$ -13.84M$ -17.40M$ -15.44M$ -5.33M$ -1.94M$ -2.26M
EBIT
$ -15.94M$ -14.77M$ -14.71M$ -5.95M$ -3.51M$ 123.77M
EBITDA
$ -15.94M$ -14.77M$ -14.71M$ -5.95M$ -3.51M$ 123.77M
Currency in USD

Portage Biotech Inc Earnings and Revenue History


What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis